chronic hepatitis


Also found in: Dictionary, Thesaurus, Acronyms, Encyclopedia.
Related to chronic hepatitis: Chronic Hepatitis B

chron·ic hep·a·ti·tis

any of several types of hepatitis persisting for longer than 6 months, often progressing to cirrhosis.

chronic hepatitis

Etymology: Gk, chronos, time, hēpar, liver, itis, inflammation
a state in which symptoms of hepatitis continue for several months and may increase in severity. In some cases of hepatitis B, the patient may become a lifelong carrier of the antigen and may show prolonged evidence of the infection. See also alcoholic hepatitis, anicteric hepatitis, cholestatic hepatitis, hepatitis, hepatitis A, hepatitis B, hepatitis C, hepatitis D, hepatitis E.

chronic hepatitis

Inflammation of the liver that does not improve within 6 months, excluding primary biliary cirrhosis, primary sclerosing cholangitis, alpha1 antitrypsin deficiency and Wilson’s disease. 

Aetiology
Autoimmune hepatitis, drug-induced hepatitis, HBV, HCV, HDV, chronic hepatitis of unknown origin (cryptogenic hepatitis).

Histologic clues for aetiology of chronic hepatitis
Viruses—Ground glass, fat, lymphoid aggregates, lymphocytosis, low grade.
Autoimmune—Plasma cells, rosetting, florid activity.
Drugs—Eosinophils, granulomas, mixed cellular reaction.

chronic hepatitis

Hepatology Inflammation of the liver that continues without improvement for ≥ 6 months. See Cirrhosis. Cf Acute hepatitis.

chron·ic hep·a·tit·is

(kronik hep-ă-tītis)
One of several types of liver disease persisting for longer than 6 months, often progressing to cirrhosis.

Chronic hepatitis

Long lasting inflammation of the liver due to viruses or other causes.

chronic hepatitis

carrier state of hepatitis B and C infections
References in periodicals archive ?
HBeAg and hepatitis B virus DNA as outcome predictors during therapy with peginterferon alfa-2a for HBeAg-positive chronic hepatitis B.
Therefore in the present study our objective was to examine the frequency of auto-antibodies among patients with chronic hepatitis B or C virus infection.
Cardiotoxic properties of interferon: aggravation of atrio-ventricular block during treatment of chronic hepatitis C with peginterferon--a case report].
8) The number of registered users in the SISMEDEX program, receiving treatment for chronic hepatitis B during August 2011, was 1,093 (about 0.
During the observation period of one year, 205 patients with chronic hepatitis C were treated with pegylated interferon alfa-2b plus ribavirin, 110 (53.
15) A large cross-sectional study by Poynard et al (15) identified 3 categories of progression in patients with chronic hepatitis C: (1) rapid fibrosing, chronic hepatitis C that progresses to cirrhosis in less than 20 years; (2) intermediate fibrosing, chronic hepatitis C with a median progression of 30 years; and (3) slow fibrosing, chronic hepatitis C that will not progress for at least 50 years (Figure 3).
Due to the paucity of available data regarding the development of TD in IFN-a treated chronic hepatitis C (CHC) patients in our population and since we have a higher prevalence of genotype III of hepatitis C virus in our population, there is a need to carry out further studies to assess the pattern of thyroid dysfunction that develops in our chronic hepatitis C patients, while they are receiving interferon therapy.
Conversion of T4 to T3 in Chronic Hepatitis B cases was also disturbed resulting in slight decrease of total T3 (mean 1.
The strategic plan outlines the health education, screenings, care, and research needed to reduce and eventually eliminate chronic hepatitis B among Asian Americans and Native Hawaiian and Other Pacific Islanders.
In the United States, 12 million people (one out of 20) have been infected at some time in their lives with the hepatitis B virus, more than one million people in the US have developed chronic hepatitis B infection, and more than 5,000 Americans die from hepatitis B-related liver complications each year.
NASDAQ:IDIX), Cambridge, Mass, has announced that the Swissmedic has approved telbivudine as a new treatment for chronic hepatitis B (CHB) in compensated patients with evidence of viral replication and active liver inflammation.

Full browser ?